Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Health Canada proposes new labeling for acetaminophen

Concerns over liver damage have prompted the new measure.

Health Canada is thinking of changing the labeling on acetaminophen, because of liver concerns.

According to The Canadian Press, acetaminophen is the leading cause of liver injuries in Canada, and, as a result, the department is reviewing the maximum number of the maximum recommended daily dose of the drug.

"We're looking both at what the ... maximum unit dose should be for non-prescription products and prescription products as well as what should be prescription and non-prescription," Dr. Supriya Sharma, a Health Canada official, told the news outlet.

Health Canada is also considering requiring all liquid medications for children that contain acetaminophen be "sold with an accurate dosing device to minimize the risk of overdose," according to the report.

An estimated 4,000 hospitalizations a year are attributed to acetaminophen overdoses, according to the article.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?